Sustained Improvements in Cognitive and Emotional Functioning Following Home-based Neuromodulation in Multiple Sclerosis and Cannabis Use Disorder

Janus Kinase Inhibitor Therapy in Patients With Multiple Sclerosis and Co-morbid Conditions

KITE-363: An Autologous Anti-CD19/CD20 CAR-T Product for the Treatment of Neuroinflammatory Autoimmune Diseases